GI
BIO icon

Gradient Investments’s Bio-Rad Laboratories Class A BIO Stock Holding History

Gradient Investments’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2
Closed -$646 – 1304
2023
Q4 		$646 Hold
2
– – ﹤0.01% 1532
2023
Q3 		$717 Hold
2
– – ﹤0.01% 1469
2023
Q2 		$758 Buy
+2
New +$814 ﹤0.01% 1442
2023
Q1 		– Sell
-3
Closed -$1.26K – 1522
2022
Q4 		$1.26K Buy
+3
New +$1.21K ﹤0.01% 1158
2021
Q3 		– Sell
-1
Closed -$1K – 1145
2021
Q2 		$1K Buy
+1
New +$609 ﹤0.01% 1046
2021
Q1 		– Sell
-2
Closed -$1K – 1153
2020
Q4 		$1K Hold
2
– – ﹤0.01% 1017
2020
Q3 		$1K Buy
+2
New +$1.01K ﹤0.01% 1022
2019
Q1 		– Sell
-29
Closed -$7K – 875
2018
Q4 		$7K Buy
+29
New +$7.78K ﹤0.01% 645

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $18.8B AUM 17.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $43.1B AUM 23.42% 1-Year Est. Return